Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. - Wikidata - wikimedia - TriplyDB

Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.

Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.

http://www.wikidata.org/entity/Q45256209

about

Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?Helicobacter pylori eradication for the prevention of gastric neoplasia Antioxidant supplements for preventing gastrointestinal cancers Chinese herbal medicine alone or combined with vitamins for gastric precancerous lesions Antioxidant supplements for preventing gastrointestinal cancers Role of bacteria in oncogenesis New advances in targeted gastric cancer treatment Helicobacter pylori Infection Synergistic with IL-1β Gene Polymorphisms Potentially Contributes to the Carcinogenesis of Gastric Cancer Gastric Cancer: How Can We Reduce the Incidence of this Disease?Non-pharmacological treatment of Helicobacter pylori Diagnosis and management of gastric dysplasia Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance Molecular cancer prevention: Current status and future directions Exploring alternative treatments for Helicobacter pylori infection The diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert Commentary Gastric cancer: prevention, screening and early diagnosis Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis Notes from the field: "green" chemoprevention as frugal medicine Diagnosis and management of high risk group for gastric cancer Clinical epidemiology of gastric cancer Cancer prevention and control: alarming challenges in China The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America Screening and treating Helicobacter pylori infection for gastric cancer prevention on the population level.Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portu Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history.Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials Helicobacter pylori antibody responses in association with eradication outcome and recurrence: a population-based intervention trial with 7.3-year follow-up in China.The association between vacA or cagA status and eradication outcome of Helicobacter pylori infection: A meta-analysis.Effect of Helicobacter pylori eradication on gastric carcinogenesis.Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer.Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy.At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.Pathology of gastric intestinal metaplasia: clinical implications.Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections.Effects of selenium supplements on cancer prevention: meta-analysis of randomized controlled trials.Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer.Prevention of Gastric Cancer: When is Treatment of Helicobacter Pylori Warranted?Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer.

P2860

Q21090716-6A299337-D129-4786-A886-541C4A26FF92 Q24186365-FC1102C2-93B1-40C5-B267-011CFEC6A213 Q24242191-6D8F68FC-FCBD-427A-B06C-19F7276EC561 Q24243598-00553E4C-88A3-4FBC-9284-B1A97DF8B140 Q24245704-F5777713-D3B3-432C-B726-7B7CFF18159E Q24633180-C0BA0E51-7C6E-40C4-9B53-3086DD8EB407 Q26738548-55E2938E-C575-4575-AE3B-EA61A2C9B78D Q26748588-61BE6C72-0691-49BA-B44C-853F856874CB Q26749352-C7F90F97-9BD6-4999-B5E3-D575C4C0AD9A Q26751181-8A5C8ADF-85FE-42CA-A316-181B7D07BDFB Q26765128-ECA56B3B-EF63-4B5F-BA46-FACD85D9213E Q26774447-47EEB0C5-BAD9-4E7C-B980-2D1329F6FF94 Q26797207-3DB35714-0609-4CDD-8499-0D6DD2512082 Q26828017-B5765656-FFA3-48DB-9CEB-24AF5DB4761C Q26852409-830B3351-96D2-4290-8B49-6F632C7C1250 Q26860418-1C04D5C8-5558-42F1-8FB9-AE57EF7C851F Q26864431-847E17B8-2DE7-44DB-87AF-35FC85104FE2 Q27021094-A48B89C6-5AE1-43D7-A8C5-984737D162BF Q28084323-9D2534AB-DE02-42BE-81C6-AEE696DAA276 Q28085054-D97F10FB-2DBF-46B5-925A-4747B09286B7 Q28396786-56C615EF-FCAA-4447-8AD9-72C461EE2D15 Q30217199-6E6B4D2F-F894-45C8-8883-9281FB55AF91 Q30239019-630816CD-CE8B-4ACB-9942-7026200BBD05 Q30426539-E9CC64D4-5CF4-4EFE-BDDB-FCC6E9F1F073 Q33338257-A3EAB244-23D3-4734-ADB0-FDE2F76CC0BA Q33636554-D1FEDE4B-3F79-4571-AF80-A6A991FCFAD0 Q33649953-B688170E-D3A1-42BC-9BCC-E55D10F0ECD6 Q33663880-565195AA-CE01-42EE-B1A8-AD4422A11A82 Q33708748-359928E1-1E4C-4578-BAD8-FDBB2BB6EC3F Q33792622-997E318A-D62D-4D49-A25E-9E0297C5259A Q33822961-904C2153-2C25-46E7-9F3A-661C66478838 Q33868331-8745CDD1-7CE1-4C41-9347-B4F559F7B5F1 Q33911623-5DF526F7-8FB4-4AB1-967B-F7833EAE335C Q33954445-5D8929E4-300A-49B0-BE11-15BC7719F284 Q33998494-C47CAA7C-42E1-47E4-A0E7-5283B43D3ADD Q34049557-8C37E48C-2E7C-467F-89EF-C1AA25DBC5EC Q34067951-96C1F4AE-2C12-4B70-B922-918170703FAD Q34157164-DAD8F53D-A18F-4D32-B0F3-7E5F4BB97835 Q34197057-FE01EC82-1235-4183-A949-D51ABDDA9293 Q34202973-35F1F591-71A2-4BA3-A89B-E0A1276BFB82

P2860

Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.

http://www.wikidata.org/entity/Q45256209

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Randomized double-blind factor ...... precancerous gastric lesions.

@en

Randomized double-blind factor ...... precancerous gastric lesions.

@nl

type

label

Randomized double-blind factor ...... precancerous gastric lesions.

@en

Randomized double-blind factor ...... precancerous gastric lesions.

@nl

prefLabel

Randomized double-blind factor ...... precancerous gastric lesions.

@en

Randomized double-blind factor ...... precancerous gastric lesions.

@nl

P1433

Q45256209-DFAEF0C1-707E-4FEE-94C9-9C0210254A05

P1476

Q45256209-46909249-AC22-46B5-92D8-2DB737C866DE

P2093

Q45256209-06A919D1-D294-42FC-8303-5E2B91913E83

Q45256209-12EE80F6-CBA5-4D44-8C85-6E60A3541D5F

Q45256209-15FCE418-2031-47F2-80C1-959024563911

Q45256209-1CA5B2FE-9030-481B-8A6C-543A226EE02D

Q45256209-3725CE37-8161-47DE-A360-45D085868CAC

Q45256209-37842C11-4A1D-4DEB-82F6-8DE6B435A775

Q45256209-59305263-A5AA-4F00-93DE-713B5DE63019

Q45256209-61EC14E2-81D4-41EC-8592-F5D241E6AD71

Q45256209-99F9BB5E-F650-4894-95EC-25C828FA8B7F

Q45256209-B964D328-E774-425A-A278-89854476E906

P2860

Q45256209-1EA29BF7-0DF2-4C55-A610-0A6FD60D20BF

Q45256209-20528BD4-27D2-4751-B2BD-1FF578EA0C94

Q45256209-24926B9D-28D5-4AE6-B50A-934E1EBB71E5

Q45256209-36FB0187-ED80-4D80-84DB-E5C0174F633D

Q45256209-56EB3936-2136-4C38-B1A5-582BB2C74157

Q45256209-84B454B6-9DBD-4006-8C58-A2C204C88CB2

Q45256209-9162777E-9B28-4D40-83E8-DBB43610DD55

Q45256209-924D8A1F-378B-4878-9FF1-0C31E97C7157

Q45256209-9A21B3C6-C240-466C-B9CB-35118CDD2982

Q45256209-9EF2F391-5F3C-453B-BF3D-E79778E93EA7

P304

Q45256209-771541FE-51A2-4D3B-8C41-187C2EE8F090

P31

Q45256209-EA8A18C4-9A75-4464-BFF6-ED16519DEF0E

P356

Q45256209-37921833-7F69-4AE9-9A38-99BCBA8C376F

P407

Q45256209-5C9DDB81-8295-4DD4-A1EC-C933E3D8A224

P433

Q45256209-028AED0F-B036-4B11-8ECE-EAA78C35C1B8

P478

Q45256209-95F1C3C7-A1C8-4FC9-897B-AC15D7A3164D

P577

Q45256209-AEECCC81-F373-438D-BA41-637837EAE591

P5875

Q45256209-0DE04E8A-BAAD-4528-A542-28E88AF0CDCB

P698

Q45256209-8F06E13D-6158-4D71-8F32-9F3A9248E805

P356

P1433

Journal of the National Cancer Institute

P1476

Randomized double-blind factor ...... precancerous gastric lesions.

@en

P2093

David Pee

http://www.w3.org/2001/XMLSchema#string

Guang-wei Xu

http://www.w3.org/2001/XMLSchema#string

Ji-you Li

http://www.w3.org/2001/XMLSchema#string

Joseph F Fraumeni

http://www.w3.org/2001/XMLSchema#string

Jun-ling Ma

http://www.w3.org/2001/XMLSchema#string

Kai-feng Pan

http://www.w3.org/2001/XMLSchema#string

Lian Zhang

http://www.w3.org/2001/XMLSchema#string

Linda M Brown

http://www.w3.org/2001/XMLSchema#string

Mao-lin Jin

http://www.w3.org/2001/XMLSchema#string

Mitchell H Gail

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Helicobacter pylori infection and the development of gastric cancer

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data.

Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated.

Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis.

Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts.

Long term follow up of patients treated for Helicobacter pylori infection.

Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial

P304

974-983

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJJ264

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6935610

http://www.w3.org/2001/XMLSchema#string

P698

16849680

http://www.w3.org/2001/XMLSchema#string